A Cold Solution to a Painful Problem: Cryoablation After Mesothelioma Surgery

For people living with pleural mesothelioma, pain is a constant companion. It comes from the tumor pressing against the chest lining, from fluid accumulating around the lungs, and, for those who undergo surgery, from the operation itself. Managing that pain without creating new problems has long been one of the most difficult challenges in mesothelioma care.

Now, a new study from thoracic surgeon Dr. Jeffrey B. Velotta and colleagues points toward a technique that could change the post-surgical experience for mesothelioma patients: intercostal nerve cryoablation, or the temporary freezing of nerves between the ribs.

How the Procedure Works

The idea is straightforward even if the name isn’t. During surgery and specifically during a pleurectomy decortication (the lung-sparing procedure known as PD), surgeons apply a specialized probe to nerves running between the fourth and eighth ribs. The probe delivers extreme cold, temporarily disabling those nerves’ ability to transmit pain signals from the chest wall to the brain. Over time, the nerves recover on their own, so as the patient recovers from surgery and the pain subsides, the nerves also get back to normal.

The goal isn’t to eliminate pain medication entirely. It’s to reduce how much is needed. Opioids, while effective for pain control, also carry their own serious risks and side effects.

Why Reducing Opioids is Important to Patients

Opioid medications like oxycodone and hydromorphone can be highly effective at controlling severe post-surgical pain, but for mesothelioma patients, the side effects are especially problematic. Drowsiness, confusion, nausea, constipation, and breathing difficulties are all common. For someone already struggling with compromised lung function and physical weakness, these effects can delay or derail recovery entirely.

After major chest surgery, patients are expected to do breathing exercises, walk short distances, and participate in pulmonary rehabilitation relatively quickly. Heavy sedation from opioids makes that participation harder. It can extend hospital stays, increase the risk of complications, and in some cases lead to long-term dependence.

This is why researchers have been looking for “opioid-sparing” approaches: these are ways to keep patients comfortable while reducing their exposure to narcotic medications.

What this Research Study Found

The study followed 64 pleural mesothelioma patients who had surgery between 2015 and 2024. Of those, 22 received cryoablation during their procedure and 42 did not. The results were notable.

Patients in the cryoablation group used roughly 40% less opioid medication overall. Close to twice as many of them required no opioids at all during their hospital stay. Crucially, their reported pain scores were similar to those who received standard care, meaning they weren’t simply enduring more discomfort. And the procedure did not appear to cause additional complications or dangerous nerve-related effects.

The study’s authors were careful to note the limitations: 64 patients is a relatively small sample, and more research is needed before cryoablation becomes a standard part of mesothelioma surgery. Still, the signal is encouraging.

Pain Is More Than Physical

It’s worth remembering that pain in mesothelioma doesn’t only affect the body. Chronic discomfort disrupts sleep, erodes mood, heightens anxiety, and strains relationships. Caregivers who watch a loved one suffer often carry their own heavy emotional burden, feeling helpless when pain medication doesn’t seem to be enough.

Patients sometimes hesitate to report pain, not wanting to “complain.” But communicating honestly with the care team about pain, especially when it’s interfering with sleep, movement, or breathing, is essential. Pain management is not peripheral to cancer care. It is central to it.

Palliative care specialists, social workers, counselors, and support groups can all help patients and families navigate the emotional weight of this experience alongside the physical one.

No One-Size-Fits-All Answer

Even if cryoablation becomes widely available, it is not looking to replace the full pain management arsenal. It will be one piece of a larger picture. Pain after mesothelioma surgery varies widely depending on the disease stage and location, the type of procedure, a patient’s other health conditions, and individual pain tolerance. Most patients will still need a combination of approaches, which may include epidurals or nerve blocks, acetaminophen, gabapentin, physical therapy, breathing exercises, and targeted opioid use.

Cryoablation, if the research continues to support it, may eventually join that toolkit as a way to make the other pieces more manageable.

Questions Worth Asking Before Surgery

Patients preparing for mesothelioma surgery may want to discuss pain management directly with their surgical team ahead of time. Questions like: What methods will be used to control pain after the operation? Will nerve blocks or cryoablation be available? What side effects should I expect from the medications? How long does post-surgical pain typically last? These conversations can help patients and families feel more prepared, and may open the door to options they didn’t know existed.

The Bigger Picture

Mesothelioma research is advancing on multiple fronts simultaneously. Immunotherapy, surgical techniques, and now post-surgical pain management are all areas where new findings are gradually reshaping what’s possible for patients. A 40% reduction in opioid use after major chest surgery isn’t a cure, but for the person in the hospital bed it can represent a significant difference in how recovery feels and the subsequent pace of recovery itself.

Note: This article is based on a study published in the Journal of Thoracic Disease by Dr. Jeffrey B. Velotta and colleagues, examining intercostal nerve cryoablation in pleural mesothelioma patients.